Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
32.80    0.10 (0.31%)
Bid:
32.60
Ask:
33.00
Spread: 0.40 (1.227%)
Market Cap: £24.08m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Trading Statement

30 Apr 2025 07:00

RNS Number : 7135G
Carclo plc
30 April 2025
 

30 April 2025

Carclo plc

Trading Update

Carclo plc ("Carclo", the "Group" or the "Company"), a global leader in precision engineering solutions, today issues a trading update for the year ended 31 March 2025.

Health & Safety Excellence

Prioritising health and safety has resulted in Carclo's Health & Safety culture becoming fundamentally transformed. This is evidenced by improvement in a key metric, the Incident Frequency Rate (a measure of the number of safety incidents per 100,000 hours worked ), which has improved dramatically from 2.28 in FY24 to 0.69 in FY25 - testament to our identity as a company that delivers measurable results.

Group Financial Performance and Strategic Execution

The Group's disciplined execution of our strategic priorities - strengthening the balance sheet, optimising assets, enhancing margins, and delivering global operational excellence - has yielded substantial progress throughout the financial year.

Trading performance for the year ended 31 March 2025 exceeded management expectations, with strong margin expansion in the second half. Net debt (including leases) closed at £19.3 million, representing a significant reduction of £10.2 million compared to £29.5 million at 31 March 2024, reinforcing the Group's financial resilience and strategic flexibility.

As announced on 25 April 2025, a significant milestone was achieved with the establishment of a new partnership with BZ Commercial Finance DAC, creating a more robust financial platform that enhances both stability and strategic flexibility for future growth investment, as well as funding the recovery plan for the Group Pension Scheme.

Key financial metrics demonstrate material progress towards our medium-term objectives, with notable improvements in Return on Sales (ROS) and Return on Capital Employed (ROCE) against our strategic targets of 10% and 25%, respectively. Cash generation remained consistently strong across the period, underpinned by enhanced operational performance, disciplined working capital management and strategic capital allocation.

CTP Design & Engineering

The Design & Engineering (D&E) business has continued its trajectory of excellence, developing sophisticated, bespoke solutions that address complex customer challenges while strengthening our technical capabilities. While the finalisation of several significant projects reduced short-term revenue, strategic investments in asset revitalisation and next-generation automation technologies have established a solid foundation for sustainable operational performance improvements.

CTP Manufacturing Solutions

The strategic restructuring of US operations represents a significant achievement, culminating in the successful closure of the Tucson facility and the seamless integration of manufacturing capabilities into Pennsylvania operations. This consolidation has delivered measurable improvements in asset utilisation metrics, operational responsiveness, and manufacturing efficiency.

In EMEA, our factory specialisation strategy continues to drive competitive advantage. The strategic alignment of long-run production excellence at our UK facility, complemented by agile, medium-run capabilities at our Central European operation, has created an optimal balance of efficiency and flexibility. This configuration enables precise alignment with diverse customer requirements while maximising operational effectiveness across the EMEA market.

The APAC manufacturing platform has advanced significantly by implementing advanced multi-component moulding capabilities. This technical enhancement supports regional customers with expedited delivery timeframes and substantially reduced supply chain complexity in key growth markets.

The Group's deployment of standardised manufacturing platforms across its global operations provides significant strategic resilience against ongoing geopolitical uncertainties. This approach enables production flexibility and rapid reallocation capabilities, positioning Carclo to navigate regional disruptions while maintaining continuity of supply for multinational customers - a competitive advantage in today's complex global trade environment.

Speciality Division

Integrating Aerospace and Light & Motion operations into a consolidated Speciality Division has delivered exceptional results, achieving record revenue performance and near-peak profitability. This success reflects robust market demand and the strategic refocusing of the product portfolio toward higher-value precision solutions.

Particularly noteworthy is the strategic transformation of precision machining capabilities, which now constitute 62% of the division's output compared to 27% three years ago. The strategic focus on the Repair, Maintenance, & Overhaul (RMO) sector, combined with targeted expansion of machining capabilities across UK and French operations, has generated exceptional compound annual growth in this high-value segment.

The Aerospace sector has demonstrated robust momentum, with medium-term strategic expansion into South Asian markets complementing established operations. This geographical diversification strategy, underpinned by a commitment to precision engineering excellence, positions the division for continued sustainable growth in these premium market segments.

Outlook

The Group is well positioned to build upon its positive trajectory, notwithstanding an increasingly complex global backdrop. Heightened geopolitical tensions, evolving trade dynamics, and continued volatility in raw material costs will remain key factors influencing global supply chains.

Under the Group's strategic leadership over the past two years, Carclo has built a flexible global manufacturing network underpinned by unified "One Carclo" global standards. Our deliberate strategy of "manufacture in the region, for the region" - combining regional resilience with globally consistent quality and service - positions the Group to react quickly and effectively to geopolitical shifts, trade barriers, and evolving customer requirements. In an increasingly fragmented world, Carclo's model is not only resilient but a clear competitive differentiator.

Further margin enhancement is anticipated as the full benefits of operational optimisation initiatives materialise across all business units. Disciplined approach to cash management and the ongoing operational excellence programme are expected to drive sustained financial resilience and strategic flexibility.

Growth in the medium-term will focus on accelerating expansion in the Life Sciences sector, where demand for high-precision solutions continues to grow, alongside continued strong momentum in our Speciality Division, particularly across aerospace and optical applications. These initiatives are fully aligned with our strategic ambition to drive sustainable top-line growth and deliver enduring value for all stakeholders.

We will provide further details in our full-year results for the year ended 31 March 2025, which will be released in July 2025.

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU NO. 596/2014) WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN

 

 

About Carclo plc

Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange. The Carclo Group is a global leader in high-precision components with comprehensive, end-to-end manufacturing capabilities. With expertise spanning mould design, automation, production, assembly, and printing, Carclo supports critical growth sectors, particularly life sciences, aerospace, and optics, with tailored, precision solutions. 

 

LEI: 21380078MEM399JPI956

 

Enquiries:

Carclo plc +44 (0) 20 8685 0500

Frank Doorenbosch - Chief Executive Officer

Ian Tichias - Chief Financial Officer

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGZGZDLLFGKZM
Date   Source Headline
6th Dec 20226:29 pmRNSHolding(s) in Company - Replacement
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
30th Nov 20227:00 amRNSHalf-year Report
15th Nov 20227:05 amRNSNotice of Interim Results & Investor Presentation
15th Nov 20227:00 amRNSDirectorate Change
7th Nov 20227:00 amRNSBoard Changes
18th Oct 20227:00 amRNSTrading Update
13th Oct 20221:22 pmRNSHolding(s) in Company
6th Oct 20221:05 pmRNSAppointment of Chief Executive Officer
16th Sep 20223:16 pmRNSHolding(s) in Company
5th Sep 20227:00 amRNSTripartite Financing Agreement Secured
2nd Sep 202212:51 pmRNSHolding(s) in Company - Correction
2nd Sep 202210:37 amRNSHolding(s) in Company
1st Sep 20223:48 pmRNSHolding(s) in Company
1st Sep 20223:20 pmRNSResults of Annual General Meeting
15th Aug 20227:00 amRNSChange of Financial Adviser and Corporate Broker
4th Aug 20227:00 amRNSDirector/PDMR Shareholding
25th Jul 202211:10 amRNS2022 Annual Report and Notice of AGM
18th Jul 20224:41 pmRNSSecond Price Monitoring Extn
18th Jul 20224:35 pmRNSPrice Monitoring Extension
12th Jul 20223:56 pmRNSHolding(s) in Company
30th Jun 20227:20 amRNSNotice of Investor Presentation
30th Jun 20227:00 amRNSFinal Results
28th Jun 20227:00 amRNSNotice of Preliminary Results
7th Jun 20227:00 amRNSDirectorate Change
29th Apr 20227:00 amRNSFull Year Trading Update
9th Mar 20224:41 pmRNSSecond Price Monitoring Extn
9th Mar 20224:36 pmRNSPrice Monitoring Extension
21st Jan 20224:41 pmRNSSecond Price Monitoring Extn
21st Jan 20224:35 pmRNSPrice Monitoring Extension
18th Jan 20227:00 amRNSDirector/PDMR Shareholding
30th Dec 20214:42 pmRNSSecond Price Monitoring Extn
30th Dec 20214:36 pmRNSPrice Monitoring Extension
7th Dec 20214:41 pmRNSSecond Price Monitoring Extn
7th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20212:57 pmRNSHolding(s) in Company
25th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSDirector/PDMR Shareholding
19th Nov 20217:00 amRNSHalf Year Results
5th Nov 20217:00 amRNSNotice of Interim Results & Investor Presentation
2nd Sep 20213:08 pmRNSResults of Annual General Meeting
2nd Sep 20217:00 amRNSAGM Trading Update
6th Aug 20217:00 amRNSDirector/PDMR Shareholding
26th Jul 20212:47 pmRNS2021 Annual Report & Notice of AGM
1st Jul 20217:00 amRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSDirector/PDMR Shareholding
30th Jun 20219:29 amRNSNotice of Investor Presentation
30th Jun 20217:00 amRNSPreliminary Results for the year ended 31 March 21

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.